Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropyfluorophosphate
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 106 (2) , 295-310
- https://doi.org/10.1016/0041-008x(90)90249-t
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Improving toxicology testing protocols using computer simulationsToxicology Letters, 1989
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- Risk Assessment Extrapolations and Physiological ModelingToxicology and Industrial Health, 1985
- Role of aliesterase in organophosphate poisoning*1Fundamental and Applied Toxicology, 1984
- Organophosphate detoxicating hydrolases in different vertebrate speciesComparative Biochemistry and Physiology Part C: Comparative Pharmacology, 1983
- Pharmacokinetics of 1-β-d-arabinofuranosylcytosine (Ara-C) deamination in several speciesBiochemical Pharmacology, 1973
- Changes in peripheral cholinergic systems following development of tolerance to the anticholinesterase diisopropylfluorophosphateToxicology and Applied Pharmacology, 1973
- Reactions between alkyl phosphates and acetylcholinesterase from different speciesComparative Biochemistry and Physiology Part B: Comparative Biochemistry, 1972
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961
- The chemical basis of the “ageing process” of DFP-inhibited pseudocholinesteraseBiochimica et Biophysica Acta, 1959